Promoter shareholding in Brawn Biotech increased slightly YoY and QoQ, indicating some insider confidence, but remains stagnant compared to sector averages.

Institutional shareholding has not changed at all, reflecting a lack of interest or confidence from smart money, which is concerning in a declining public sentiment.

Public shareholding has decreased significantly YoY, showing a clear trend of retail investors selling off their positions, aligning with the broader sector trend of no growth.